Alan Jackson discusses his battle with degenerative nerve disease.


Alan Jackson discusses his battle with degenerative nerve disease.

Alan Jackson has made his battle with a degenerative neurological illness public.

On Tuesday’s broadcast of Today, the 62-year-old country music singer said that he was diagnosed with Charcot-Marie-Tooth illness 10 years ago, a neurological disorder that affects the arms and legs.

“I’ve been hesitant to discuss this publicly or with my fans. “I received this neuropathy – a genetic neurological illness – from my father,” Jackson explained.

CMT condition can lead to muscular weakness and balance problems. According to Jackson, there is no cure for the ailment, and he has been suffering from its symptoms “for years.”

“It’s becoming very evident. I’m very aware that I’m stumbling around on stage. Now I’m having some difficulty balancing, even in front of the microphone, and I’m just feeling extremely uneasy,” Jackson explained.

He went on to say, “It’s not going to kill me — it’s not fatal.” “However, it has something to do with muscular dystrophy and Parkinson’s disease.”

Jackson stated that he is relieved to have made his situation public and that he intends to continue performing.

“I never wanted to do the big retirement tour that everyone else does, then take a year off and come back,” he explained. “I think that’s a little cheesy.” I’m not implying that I won’t be able to go on tour. I’ll try to help in any way I can.”

“It’s been bothering me for a long time.”

Alan Jackson, the country music icon, was diagnosed with a degenerative nerve ailment that affected his ability to walk ten years ago. For the first time, he tells @JennaBushHager about his health problems.— TODAY (@TODAYshow) September 28, 2021

Where Have You Gone, Jackson’s 21st studio album, was released in May. Last week, he launched a music video for his song of the same name.

At, Nokia News provides an independent, constantly updated stream of breaking news from the United States and throughout the world.


Comments are closed.